Prapela careers

Since 2018, we have been awarded over $1.7M to help newborns breathe, relax and sleep. Our breakthrough mattress with its unique SVS technology has been proven in 3 published, peer-review studies. SVS is non-habit forming and does not disrupt infant sleep cycles. Our first medical application is the Prapela SVS hospital bassinet pad to help opioid-exposed babies. Our first consumer product is the Prapela SVS baby box with an SVS pad to help babies relax and sleep.